Unknown

Dataset Information

0

Cancer-associated protein kinase C mutations reveal kinase's role as tumor suppressor.


ABSTRACT: Protein kinase C (PKC) isozymes have remained elusive cancer targets despite the unambiguous tumor promoting function of their potent ligands, phorbol esters, and the prevalence of their mutations. We analyzed 8% of PKC mutations identified in human cancers and found that, surprisingly, most were loss of function and none were activating. Loss-of-function mutations occurred in all PKC subgroups and impeded second-messenger binding, phosphorylation, or catalysis. Correction of a loss-of-function PKCβ mutation by CRISPR-mediated genome editing in a patient-derived colon cancer cell line suppressed anchorage-independent growth and reduced tumor growth in a xenograft model. Hemizygous deletion promoted anchorage-independent growth, revealing that PKCβ is haploinsufficient for tumor suppression. Several mutations were dominant negative, suppressing global PKC signaling output, and bioinformatic analysis suggested that PKC mutations cooperate with co-occurring mutations in cancer drivers. These data establish that PKC isozymes generally function as tumor suppressors, indicating that therapies should focus on restoring, not inhibiting, PKC activity.

SUBMITTER: Antal CE 

PROVIDER: S-EPMC4313737 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC6637204 | biostudies-literature
| S-EPMC5193403 | biostudies-literature
| S-EPMC3807107 | biostudies-literature
| S-EPMC3546152 | biostudies-other
| S-EPMC7198492 | biostudies-literature
| S-EPMC3115913 | biostudies-literature
| S-EPMC8114703 | biostudies-literature
| S-EPMC8183929 | biostudies-literature
| S-EPMC3778137 | biostudies-literature
| S-EPMC3594444 | biostudies-literature